168 related articles for article (PubMed ID: 10989544)
1. [Iron overload and cancer].
Blanc JF; Bioulac-Sage P; Balabaud C
Bull Acad Natl Med; 2000; 184(2):355-63. PubMed ID: 10989544
[TBL] [Abstract][Full Text] [Related]
2. [Premalignant lesions and hepatocellular carcinoma on non cirrhotic liver overloaded with iron].
Attia A; Blanc JF; Saric J; Balabaud C; Bioulac-Sage P
Gastroenterol Clin Biol; 2000 Oct; 24(10):955-9. PubMed ID: 11084432
[TBL] [Abstract][Full Text] [Related]
3. Dietary iron overload in the African and hepatocellular carcinoma.
Kew MC; Asare GA
Liver Int; 2007 Aug; 27(6):735-41. PubMed ID: 17617115
[TBL] [Abstract][Full Text] [Related]
4. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
[TBL] [Abstract][Full Text] [Related]
5. Iron in the pathogenesis of hepatocellular carcinoma.
Fargion S; Piperno A; Fracanzani AL; Cappellini MD; Romano R; Fiorelli G
Ital J Gastroenterol; 1991 Dec; 23(9):584-8. PubMed ID: 1662094
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry.
Ko C; Siddaiah N; Berger J; Gish R; Brandhagen D; Sterling RK; Cotler SJ; Fontana RJ; McCashland TM; Han SH; Gordon FD; Schilsky ML; Kowdley KV
Liver Int; 2007 Dec; 27(10):1394-401. PubMed ID: 17927713
[TBL] [Abstract][Full Text] [Related]
7. [Iron overload and liver diseases (except for hemochromatosis and dysmetabolic hepatosiderosis].
Dhumeaux D; Hezode C
Bull Acad Natl Med; 2000; 184(2):349-54. PubMed ID: 10989543
[TBL] [Abstract][Full Text] [Related]
8. Compound heterozygosity for haemochromatosis gene mutations and hepatic iron overload in allogeneic bone marrow transplant recipients.
Grigg AP; Bhathal PS
Pathology; 2001 Feb; 33(1):44-9. PubMed ID: 11280607
[TBL] [Abstract][Full Text] [Related]
9. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
Furutani T; Hino K; Okuda M; Gondo T; Nishina S; Kitase A; Korenaga M; Xiao SY; Weinman SA; Lemon SM; Sakaida I; Okita K
Gastroenterology; 2006 Jun; 130(7):2087-98. PubMed ID: 16762631
[TBL] [Abstract][Full Text] [Related]
10. Hepatic iron overload and hepatocellular carcinoma.
Kew MC
Cancer Lett; 2009 Dec; 286(1):38-43. PubMed ID: 19081672
[TBL] [Abstract][Full Text] [Related]
11. Iron, HCV, and liver cancer: hard metal setting the pace?
Mueller S; Afdhal NH; Schuppan D
Gastroenterology; 2006 Jun; 130(7):2229-34. PubMed ID: 16762645
[No Abstract] [Full Text] [Related]
12. [Iron storage disease].
Horváth G; Dávid K
Orv Hetil; 2004 Sep; 145(39):1979-84. PubMed ID: 15553908
[TBL] [Abstract][Full Text] [Related]
13. C282Y and H63D mutations of the haemochromatosis gene in patients with iron overload.
Jorquera F; Domínguez A; Díaz-Golpe V; Espinel J; Muñoz F; Herrera A; Fernández-Gundín MJ; Vivas S; Olcoz JL
Rev Esp Enferm Dig; 2001 May; 93(5):293-302. PubMed ID: 11488107
[TBL] [Abstract][Full Text] [Related]
14. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.
Kowdley KV; Brandhagen DJ; Gish RG; Bass NM; Weinstein J; Schilsky ML; Fontana RJ; McCashland T; Cotler SJ; Bacon BR; Keeffe EB; Gordon F; Polissar N;
Gastroenterology; 2005 Aug; 129(2):494-503. PubMed ID: 16083706
[TBL] [Abstract][Full Text] [Related]
15. Hepatic siderosis, fibrosis and cirrhosis: the association with hepatocellular carcinoma in high-risk population.
Jaskiewicz K; Banach L; Lancaster E
Anticancer Res; 1997; 17(5B):3897-9. PubMed ID: 9427800
[TBL] [Abstract][Full Text] [Related]
16. Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis?
Adams PC
Am J Gastroenterol; 2001 Feb; 96(2):567-9. PubMed ID: 11232708
[TBL] [Abstract][Full Text] [Related]
17. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis.
Fujita N; Miyachi H; Tanaka H; Takeo M; Nakagawa N; Kobayashi Y; Iwasa M; Watanabe S; Takei Y
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):424-32. PubMed ID: 19190144
[TBL] [Abstract][Full Text] [Related]
18. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
19. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis.
Sorrentino P; D'Angelo S; Ferbo U; Micheli P; Bracigliano A; Vecchione R
J Hepatol; 2009 Feb; 50(2):351-7. PubMed ID: 19070395
[TBL] [Abstract][Full Text] [Related]
20. Manganese superoxide dismutase dimorphism and iron overload, hepatocellular carcinoma, and death in hepatitis C virus-infected patients.
Nahon P; Sutton A; Pessayre D; Rufat P; Ziol M; Ganne-Carrie N; Charnaux N; Trinchet JC; Gattegno L; Beaugrand M
Clin Gastroenterol Hepatol; 2007 May; 5(5):630-5. PubMed ID: 17336594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
